287 related articles for article (PubMed ID: 17915961)
1. Arsenite-enhanced procoagulant activity through phosphatidylserine exposure in platelets.
Bae ON; Lim KM; Noh JY; Chung SM; Kim H; Lee CR; Park JD; Chung JH
Chem Res Toxicol; 2007 Dec; 20(12):1760-8. PubMed ID: 17915961
[TBL] [Abstract][Full Text] [Related]
2. Trivalent methylated arsenical-induced phosphatidylserine exposure and apoptosis in platelets may lead to increased thrombus formation.
Bae ON; Lim KM; Noh JY; Chung SM; Kim SH; Chung JH
Toxicol Appl Pharmacol; 2009 Sep; 239(2):144-53. PubMed ID: 19167414
[TBL] [Abstract][Full Text] [Related]
3. Lead-induced procoagulant activation of erythrocytes through phosphatidylserine exposure may lead to thrombotic diseases.
Shin JH; Lim KM; Noh JY; Bae ON; Chung SM; Lee MY; Chung JH
Chem Res Toxicol; 2007 Jan; 20(1):38-43. PubMed ID: 17226925
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin-induced platelet procoagulant activities: an important clue for chemotherapy-associated thrombosis.
Kim SH; Lim KM; Noh JY; Kim K; Kang S; Chang YK; Shin S; Chung JH
Toxicol Sci; 2011 Nov; 124(1):215-24. PubMed ID: 21865289
[TBL] [Abstract][Full Text] [Related]
5. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity.
Jun EA; Lim KM; Kim K; Bae ON; Noh JY; Chung KH; Chung JH
Nanotoxicology; 2011 Jun; 5(2):157-67. PubMed ID: 20822370
[TBL] [Abstract][Full Text] [Related]
6. Role of cAMP-dependent protein kinase in the regulation of platelet procoagulant activity.
Yan R; Wang Z; Yuan Y; Cheng H; Dai K
Arch Biochem Biophys; 2009 May; 485(1):41-8. PubMed ID: 19268649
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E inhibition on platelet procoagulant activity: involvement of aminophospholipid translocase activity.
Kim JE; Han M; Hanl KS; Kim HK
Thromb Res; 2011 May; 127(5):435-42. PubMed ID: 21296386
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of platelet aggregation and thrombus formation by arsenic in drinking water: a contributing factor to cardiovascular disease.
Lee MY; Bae ON; Chung SM; Kang KT; Lee JY; Chung JH
Toxicol Appl Pharmacol; 2002 Mar; 179(2):83-8. PubMed ID: 11884240
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine enhances platelet procoagulant activity.
Tomasiak M; Rusak T; Gacko M; Stelmach H
Nephrol Dial Transplant; 2007 Jun; 22(6):1750-6. PubMed ID: 17308321
[TBL] [Abstract][Full Text] [Related]
10. The involvement of Na+/K(+)-ATPase in the development of platelet procoagulant response.
Tomasiak M; Stelmach H; Rusak T; Ciborowski M; Radziwon P
Acta Biochim Pol; 2007; 54(3):625-39. PubMed ID: 17653302
[TBL] [Abstract][Full Text] [Related]
11. L-carnitine inhibits a subset of platelet activation responses in chronic uraemia.
Bonomini M; Sirolli V; Dottori S; Amoroso L; Di Liberato L; Arduini A
Nephrol Dial Transplant; 2007 Sep; 22(9):2623-9. PubMed ID: 17478491
[TBL] [Abstract][Full Text] [Related]
12. Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition.
Kuijpers MJ; Munnix IC; Cosemans JM; Vlijmen BV; Reutelingsperger CP; Egbrink MO; Heemskerk JW
Microcirculation; 2008 May; 15(4):269-82. PubMed ID: 18464157
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide induces procoagulant activity through phosphatidylserine exposure and microparticle generation in endothelial cells.
Zhou J; Li H; Fu Y; Shi J; Hou J; Zhang Y; Liu X; Song P
Thromb Res; 2011 May; 127(5):466-72. PubMed ID: 21272920
[TBL] [Abstract][Full Text] [Related]
14. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
[TBL] [Abstract][Full Text] [Related]
15. Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets.
Watala C; Waczulikova I; Wieclawska B; Rozalski M; Gresner P; Gwoździński K; Mateasik A; Sikurova L
Cytometry; 2002 Nov; 49(3):119-33. PubMed ID: 12442312
[TBL] [Abstract][Full Text] [Related]
16. Procoagulant and prothrombotic effects of the herbal medicine, Dipsacus asper and its active ingredient, dipsacus saponin C, on human platelets.
Song JS; Lim KM; Kang S; Noh JY; Kim K; Bae ON; Chung JH
J Thromb Haemost; 2012 May; 10(5):895-906. PubMed ID: 22405282
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylserine exposure and other apoptotic-like events in Bernard-Soulier syndrome platelets.
Rand ML; Wang H; Bang KW; Teitel JM; Blanchette VS; Freedman J; Nurden AT
Am J Hematol; 2010 Aug; 85(8):584-92. PubMed ID: 20658588
[TBL] [Abstract][Full Text] [Related]
18. Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine.
Bonomini M; Sirolli V; Merciaro G; Antidormi T; Di Liberato L; Brummer U; Papponetti M; Cappelli P; Di Gregorio P; Arduini A
Nephrol Dial Transplant; 2005 Feb; 20(2):361-6. PubMed ID: 15598665
[TBL] [Abstract][Full Text] [Related]
19. Vasopressin acts on platelets to generate procoagulant activity.
Tomasiak M; Stelmach H; Rusak T; Ciborowski M; Radziwon P
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):615-24. PubMed ID: 18832900
[TBL] [Abstract][Full Text] [Related]
20. Effect of factor Xa inhibitors on the platelet-derived microparticles procoagulant activity in vitro and in vivo in rats.
Hérault JP; Perrin B; Jongbloet C; Pflieger AM; Bernat A; Herbert JM
Thromb Haemost; 2000 Oct; 84(4):668-74. PubMed ID: 11057868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
